We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Fed. Circ. Rules Enbrel Doesn't Infringe Ariad Patent

Law360 (June 1, 2009, 12:00 AM EDT) -- A federal appeals court has ruled that Amgen Inc.'s arthritis drug Enbrel does not infringe an Ariad Pharmaceuticals Inc. patent, affirming an order by a district court.

In an opinion written...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.